gabexate has been researched along with Rhinitis, Allergic, Perennial in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Rhinitis, Allergic, Perennial: Inflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year. The causes are usually air-borne allergens, particularly dusts, feathers, molds, animal fur, etc.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katori, M | 1 |
| Nishiyama, K | 1 |
| Iguchi, Y | 1 |
| Majima, M | 1 |
| Yao, K | 1 |
1 other study available for gabexate and Rhinitis, Allergic, Perennial
| Article | Year |
|---|---|
Reduction by a kallikrein inhibitor of the increased nasal airway resistance of allergic patients after antigen challenge.
Topics: Airway Resistance; Allergens; Animals; Antigens; Esters; Gabexate; Guanidines; Humans; Kallikreins; | 1996 |